Landscapes / Companies
Galimedix Therapeutics Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
2 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Mar 2028Phase 2 trial completes | |||
| Next date | 30 Mar 2028 · Phase 2 trial completes | ||||
| Also tested for | Geographic Atrophy of the Macula, Mild to Moderate Alzheimer's Disease | ||||
| Open drug page | |||||
About
- No active trial
- Enteric-Coated
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021